> top > docs > PubMed:23811795 > annotations

PubMed:23811795 JSONTXT

Annnotations TAB JSON ListView MergeView

Glycan-Motif

Id Subject Object Predicate Lexical cue
T1 762-782 https://glytoucan.org/Structures/Glycans/G64581RP denotes N-acetyl glucosamine

GlyCosmos6-Glycan-Motif-Image

Id Subject Object Predicate Lexical cue image
T1 762-782 Glycan_Motif denotes N-acetyl glucosamine https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G64581RP

GlyCosmos6-Glycan-Motif-Structure

Id Subject Object Predicate Lexical cue
T1 762-782 https://glytoucan.org/Structures/Glycans/G64581RP denotes N-acetyl glucosamine

sentences

Id Subject Object Predicate Lexical cue
TextSentencer_T1 0-113 Sentence denotes N-acetylglucosaminyltransferase V confers hepatoma cells with resistance to anoikis through EGFR/PAK1 activation.
TextSentencer_T2 114-305 Sentence denotes Elevated expression and activity of N-acetylglucosaminyltransferase V (Mgat5) in hepatocellular carcinoma (HCC) is a common early event involved in tumor invasion during hepatocarcinogenesis.
TextSentencer_T3 306-499 Sentence denotes A better understanding of the functional role and the molecular mechanism for Mgat5-targeted protein and downstream signaling pathway behind hepatoma invasion and metastasis is urgently needed.
TextSentencer_T4 500-618 Sentence denotes Here, we show that Mgat5 overexpression promoted anchorage-independent growth and inhibited anoikis in hepatoma cells.
TextSentencer_T5 619-854 Sentence denotes This effect was reversed by glycosyltransferase inactive mutant Mgat5 L188R transfection, α-mannosidase II inhibitor swainsonine treatment and N-acetyl glucosamine (GlcNAc) phosphotransferase (GPT) inhibitor tunicamycin administration.
TextSentencer_T6 855-1175 Sentence denotes Mgat5 overexpression increased p21-activated kinase 1 (PAK1) expression and shRNA-mediated PAK1 knockdown and kinase inactivation with kinase dead mutant PAK1 K299R coexpression or allosteric inhibitor P21-activated kinase inhibitor III (IPA3) treatment reversed anoikis resistance in Mgat5-overexpressed hepatoma cells.
TextSentencer_T7 1176-1351 Sentence denotes Furthermore, Mgat5 overexpression upregulated β-1-6-GlcNAc branched N-glycosylation and following phosphorylation of epidermal growth factor receptor (EGFR) in hepatoma cells.
TextSentencer_T8 1352-1589 Sentence denotes EGFR tyrosine kinase inhibitors AG1478 and Iressa treatment declined anchorage-independent growth and anoikis resistance, which could be rescued by constitutive active mutant PAK1 T423E coexpression in Mgat5-overexpressed hepatoma cells.
TextSentencer_T9 1590-1707 Sentence denotes Conversely, knockdown of Mgat5 reduced EGFR/PAK1-dependent anoikis resistance, which could be reversed by PAK1 T423E.
TextSentencer_T10 1708-2074 Sentence denotes These results identified Mgat5-mediated β-1-6-GlcNAc branched N-glycosylation and following activation of EGFR as a potential novel upstream molecular event for PAK1-induced anoikis resistance in hepatoma cells, implicating that molecular targeted therapeutics against Mgat5/EGFR/PAK1 might open a new avenue for personalized medicine in advanced-stage HCC patients.
T1 0-113 Sentence denotes N-acetylglucosaminyltransferase V confers hepatoma cells with resistance to anoikis through EGFR/PAK1 activation.
T2 114-305 Sentence denotes Elevated expression and activity of N-acetylglucosaminyltransferase V (Mgat5) in hepatocellular carcinoma (HCC) is a common early event involved in tumor invasion during hepatocarcinogenesis.
T3 306-499 Sentence denotes A better understanding of the functional role and the molecular mechanism for Mgat5-targeted protein and downstream signaling pathway behind hepatoma invasion and metastasis is urgently needed.
T4 500-618 Sentence denotes Here, we show that Mgat5 overexpression promoted anchorage-independent growth and inhibited anoikis in hepatoma cells.
T5 619-854 Sentence denotes This effect was reversed by glycosyltransferase inactive mutant Mgat5 L188R transfection, α-mannosidase II inhibitor swainsonine treatment and N-acetyl glucosamine (GlcNAc) phosphotransferase (GPT) inhibitor tunicamycin administration.
T6 855-1175 Sentence denotes Mgat5 overexpression increased p21-activated kinase 1 (PAK1) expression and shRNA-mediated PAK1 knockdown and kinase inactivation with kinase dead mutant PAK1 K299R coexpression or allosteric inhibitor P21-activated kinase inhibitor III (IPA3) treatment reversed anoikis resistance in Mgat5-overexpressed hepatoma cells.
T7 1176-1351 Sentence denotes Furthermore, Mgat5 overexpression upregulated β-1-6-GlcNAc branched N-glycosylation and following phosphorylation of epidermal growth factor receptor (EGFR) in hepatoma cells.
T8 1352-1589 Sentence denotes EGFR tyrosine kinase inhibitors AG1478 and Iressa treatment declined anchorage-independent growth and anoikis resistance, which could be rescued by constitutive active mutant PAK1 T423E coexpression in Mgat5-overexpressed hepatoma cells.
T9 1590-1707 Sentence denotes Conversely, knockdown of Mgat5 reduced EGFR/PAK1-dependent anoikis resistance, which could be reversed by PAK1 T423E.
T10 1708-2074 Sentence denotes These results identified Mgat5-mediated β-1-6-GlcNAc branched N-glycosylation and following activation of EGFR as a potential novel upstream molecular event for PAK1-induced anoikis resistance in hepatoma cells, implicating that molecular targeted therapeutics against Mgat5/EGFR/PAK1 might open a new avenue for personalized medicine in advanced-stage HCC patients.
T1 0-113 Sentence denotes N-acetylglucosaminyltransferase V confers hepatoma cells with resistance to anoikis through EGFR/PAK1 activation.
T2 114-305 Sentence denotes Elevated expression and activity of N-acetylglucosaminyltransferase V (Mgat5) in hepatocellular carcinoma (HCC) is a common early event involved in tumor invasion during hepatocarcinogenesis.
T3 306-499 Sentence denotes A better understanding of the functional role and the molecular mechanism for Mgat5-targeted protein and downstream signaling pathway behind hepatoma invasion and metastasis is urgently needed.
T4 500-618 Sentence denotes Here, we show that Mgat5 overexpression promoted anchorage-independent growth and inhibited anoikis in hepatoma cells.
T5 619-854 Sentence denotes This effect was reversed by glycosyltransferase inactive mutant Mgat5 L188R transfection, α-mannosidase II inhibitor swainsonine treatment and N-acetyl glucosamine (GlcNAc) phosphotransferase (GPT) inhibitor tunicamycin administration.
T6 855-1175 Sentence denotes Mgat5 overexpression increased p21-activated kinase 1 (PAK1) expression and shRNA-mediated PAK1 knockdown and kinase inactivation with kinase dead mutant PAK1 K299R coexpression or allosteric inhibitor P21-activated kinase inhibitor III (IPA3) treatment reversed anoikis resistance in Mgat5-overexpressed hepatoma cells.
T7 1176-1351 Sentence denotes Furthermore, Mgat5 overexpression upregulated β-1-6-GlcNAc branched N-glycosylation and following phosphorylation of epidermal growth factor receptor (EGFR) in hepatoma cells.
T8 1352-1589 Sentence denotes EGFR tyrosine kinase inhibitors AG1478 and Iressa treatment declined anchorage-independent growth and anoikis resistance, which could be rescued by constitutive active mutant PAK1 T423E coexpression in Mgat5-overexpressed hepatoma cells.
T9 1590-1707 Sentence denotes Conversely, knockdown of Mgat5 reduced EGFR/PAK1-dependent anoikis resistance, which could be reversed by PAK1 T423E.
T10 1708-2074 Sentence denotes These results identified Mgat5-mediated β-1-6-GlcNAc branched N-glycosylation and following activation of EGFR as a potential novel upstream molecular event for PAK1-induced anoikis resistance in hepatoma cells, implicating that molecular targeted therapeutics against Mgat5/EGFR/PAK1 might open a new avenue for personalized medicine in advanced-stage HCC patients.

GlycoBiology-GDGDB

Id Subject Object Predicate Lexical cue
_T1 709-722 http://acgg.asia/db/diseases/gdgdb?con_ui=CON00008 denotes α-mannosidase

GlycoBiology-FMA

Id Subject Object Predicate Lexical cue
_T1 51-56 FMAID:68646 denotes cells
_T2 51-56 FMAID:169002 denotes cells
_T3 399-406 FMAID:165447 denotes protein
_T4 399-406 FMAID:67257 denotes protein
_T5 612-617 FMAID:169002 denotes cells
_T6 612-617 FMAID:68646 denotes cells
_T7 762-782 FMAID:196781 denotes N-acetyl glucosamine
_T8 762-782 FMAID:82787 denotes N-acetyl glucosamine
_T9 771-782 FMAID:82797 denotes glucosamine
_T10 771-782 FMAID:196792 denotes glucosamine
_T11 1169-1174 FMAID:68646 denotes cells
_T12 1169-1174 FMAID:169002 denotes cells
_T13 1235-1243 FMAID:226028 denotes branched
_T14 1235-1243 FMAID:226027 denotes branched
_T15 1345-1350 FMAID:68646 denotes cells
_T16 1345-1350 FMAID:169002 denotes cells
_T17 1357-1365 FMAID:82768 denotes tyrosine
_T18 1357-1365 FMAID:196757 denotes tyrosine
_T19 1583-1588 FMAID:68646 denotes cells
_T20 1583-1588 FMAID:169002 denotes cells
_T21 1761-1769 FMAID:226028 denotes branched
_T22 1761-1769 FMAID:226027 denotes branched
_T23 1913-1918 FMAID:169002 denotes cells
_T24 1913-1918 FMAID:68646 denotes cells

uniprot-human

Id Subject Object Predicate Lexical cue
T1 0-31 http://www.uniprot.org/uniprot/Q06430 denotes N-acetylglucosaminyltransferase
T2 150-181 http://www.uniprot.org/uniprot/Q06430 denotes N-acetylglucosaminyltransferase
T3 0-31 http://www.uniprot.org/uniprot/Q8N0V5 denotes N-acetylglucosaminyltransferase
T4 150-181 http://www.uniprot.org/uniprot/Q8N0V5 denotes N-acetylglucosaminyltransferase
T5 0-31 http://www.uniprot.org/uniprot/Q8NFS9 denotes N-acetylglucosaminyltransferase
T6 150-181 http://www.uniprot.org/uniprot/Q8NFS9 denotes N-acetylglucosaminyltransferase
T7 92-96 http://www.uniprot.org/uniprot/Q9GZX1 denotes EGFR
T8 1327-1331 http://www.uniprot.org/uniprot/Q9GZX1 denotes EGFR
T9 1352-1356 http://www.uniprot.org/uniprot/Q9GZX1 denotes EGFR
T10 1629-1633 http://www.uniprot.org/uniprot/Q9GZX1 denotes EGFR
T11 1814-1818 http://www.uniprot.org/uniprot/Q9GZX1 denotes EGFR
T12 1293-1325 http://www.uniprot.org/uniprot/Q9GZX1 denotes epidermal growth factor receptor
T13 97-101 http://www.uniprot.org/uniprot/Q16512 denotes PAK1
T14 910-914 http://www.uniprot.org/uniprot/Q16512 denotes PAK1
T15 946-950 http://www.uniprot.org/uniprot/Q16512 denotes PAK1
T16 1009-1013 http://www.uniprot.org/uniprot/Q16512 denotes PAK1
T17 1527-1531 http://www.uniprot.org/uniprot/Q16512 denotes PAK1
T18 1634-1638 http://www.uniprot.org/uniprot/Q16512 denotes PAK1
T19 1696-1700 http://www.uniprot.org/uniprot/Q16512 denotes PAK1
T20 1869-1873 http://www.uniprot.org/uniprot/Q16512 denotes PAK1
T21 1988-1992 http://www.uniprot.org/uniprot/Q16512 denotes PAK1
T22 97-101 http://www.uniprot.org/uniprot/Q13153 denotes PAK1
T23 910-914 http://www.uniprot.org/uniprot/Q13153 denotes PAK1
T24 946-950 http://www.uniprot.org/uniprot/Q13153 denotes PAK1
T25 1009-1013 http://www.uniprot.org/uniprot/Q13153 denotes PAK1
T26 1527-1531 http://www.uniprot.org/uniprot/Q13153 denotes PAK1
T27 1634-1638 http://www.uniprot.org/uniprot/Q13153 denotes PAK1
T28 1696-1700 http://www.uniprot.org/uniprot/Q13153 denotes PAK1
T29 1869-1873 http://www.uniprot.org/uniprot/Q13153 denotes PAK1
T30 886-908 http://www.uniprot.org/uniprot/Q13153 denotes p21-activated kinase 1
T31 709-725 http://www.uniprot.org/uniprot/Q16706 denotes α-mannosidase II
T32 812-815 http://www.uniprot.org/uniprot/P24298 denotes GPT
T33 812-815 http://www.uniprot.org/uniprot/Q9H3H5 denotes GPT
T34 886-889 http://www.uniprot.org/uniprot/P38936 denotes p21
T35 886-906 http://www.uniprot.org/uniprot/Q7Z2E4 denotes p21-activated kinase
T36 886-906 http://www.uniprot.org/uniprot/Q9P286 denotes p21-activated kinase
T37 886-906 http://www.uniprot.org/uniprot/O96013 denotes p21-activated kinase
T38 886-906 http://www.uniprot.org/uniprot/Q9NQU5 denotes p21-activated kinase
T39 886-906 http://www.uniprot.org/uniprot/Q13177 denotes p21-activated kinase
T40 890-908 http://www.uniprot.org/uniprot/Q02750 denotes activated kinase 1
T41 890-908 http://www.uniprot.org/uniprot/P28482 denotes activated kinase 1
T42 890-908 http://www.uniprot.org/uniprot/P45985 denotes activated kinase 1
T43 890-908 http://www.uniprot.org/uniprot/Q07912 denotes activated kinase 1
T44 890-908 http://www.uniprot.org/uniprot/P50613 denotes activated kinase 1
T45 890-908 http://www.uniprot.org/uniprot/Q15599 denotes activated kinase 1
T46 1222-1225 http://www.uniprot.org/uniprot/Q92988 denotes β-1
T47 1748-1751 http://www.uniprot.org/uniprot/Q92988 denotes β-1
T48 1293-1316 http://www.uniprot.org/uniprot/P01133 denotes epidermal growth factor
T49 1293-1325 http://www.uniprot.org/uniprot/Q86T13 denotes epidermal growth factor receptor
T50 1303-1325 http://www.uniprot.org/uniprot/Q9NZT4 denotes growth factor receptor
T51 1303-1325 http://www.uniprot.org/uniprot/Q9UIH8 denotes growth factor receptor
T52 1303-1325 http://www.uniprot.org/uniprot/P08581 denotes growth factor receptor
T53 1357-1383 http://www.uniprot.org/uniprot/Q8TAI4 denotes tyrosine kinase inhibitors

uniprot-mouse

Id Subject Object Predicate Lexical cue
T1 0-31 http://www.uniprot.org/uniprot/P97402 denotes N-acetylglucosaminyltransferase
T2 150-181 http://www.uniprot.org/uniprot/P97402 denotes N-acetylglucosaminyltransferase
T3 812-815 http://www.uniprot.org/uniprot/P42867 denotes GPT
T4 886-889 http://www.uniprot.org/uniprot/P63028 denotes p21
T5 886-889 http://www.uniprot.org/uniprot/Q62092 denotes p21
T6 886-889 http://www.uniprot.org/uniprot/P39689 denotes p21
T7 1293-1316 http://www.uniprot.org/uniprot/P01132 denotes epidermal growth factor
T8 1293-1325 http://www.uniprot.org/uniprot/Q01279 denotes epidermal growth factor receptor

GlycoBiology-NCBITAXON

Id Subject Object Predicate Lexical cue
T1 51-56 http://purl.bioontology.org/ontology/STY/T025 denotes cells
T2 210-219 http://purl.bioontology.org/ontology/NCBITAXON/166034 denotes carcinoma
T3 244-249 http://purl.bioontology.org/ontology/STY/T051 denotes event
T4 370-379 http://purl.bioontology.org/ontology/NCBITAXON/127244 denotes mechanism
T5 612-617 http://purl.bioontology.org/ontology/STY/T025 denotes cells
T6 1169-1174 http://purl.bioontology.org/ontology/STY/T025 denotes cells
T7 1345-1350 http://purl.bioontology.org/ontology/STY/T025 denotes cells
T8 1583-1588 http://purl.bioontology.org/ontology/STY/T025 denotes cells
T9 1859-1864 http://purl.bioontology.org/ontology/STY/T051 denotes event
T10 1913-1918 http://purl.bioontology.org/ontology/STY/T025 denotes cells

GO-BP

Id Subject Object Predicate Lexical cue
T1 0-33 http://purl.obolibrary.org/obo/GO_0030144 denotes N-acetylglucosaminyltransferase V
T2 138-183 http://purl.obolibrary.org/obo/GO_0030144 denotes activity of N-acetylglucosaminyltransferase V
T3 76-83 http://purl.obolibrary.org/obo/GO_0043276 denotes anoikis
T4 592-599 http://purl.obolibrary.org/obo/GO_0043276 denotes anoikis
T5 1118-1125 http://purl.obolibrary.org/obo/GO_0043276 denotes anoikis
T6 1454-1461 http://purl.obolibrary.org/obo/GO_0043276 denotes anoikis
T7 1649-1656 http://purl.obolibrary.org/obo/GO_0043276 denotes anoikis
T8 1882-1889 http://purl.obolibrary.org/obo/GO_0043276 denotes anoikis
T9 92-96 http://purl.obolibrary.org/obo/GO_0005006 denotes EGFR
T10 1327-1331 http://purl.obolibrary.org/obo/GO_0005006 denotes EGFR
T11 1352-1356 http://purl.obolibrary.org/obo/GO_0005006 denotes EGFR
T12 1629-1633 http://purl.obolibrary.org/obo/GO_0005006 denotes EGFR
T13 1814-1818 http://purl.obolibrary.org/obo/GO_0005006 denotes EGFR
T14 1983-1987 http://purl.obolibrary.org/obo/GO_0005006 denotes EGFR
T15 138-181 http://purl.obolibrary.org/obo/GO_0047222 denotes activity of N-acetylglucosaminyltransferase
T16 138-181 http://purl.obolibrary.org/obo/GO_0008454 denotes activity of N-acetylglucosaminyltransferase
T17 138-181 http://purl.obolibrary.org/obo/GO_0008455 denotes activity of N-acetylglucosaminyltransferase
T18 138-181 http://purl.obolibrary.org/obo/GO_0047261 denotes activity of N-acetylglucosaminyltransferase
T19 138-181 http://purl.obolibrary.org/obo/GO_0008917 denotes activity of N-acetylglucosaminyltransferase
T20 138-181 http://purl.obolibrary.org/obo/GO_0017176 denotes activity of N-acetylglucosaminyltransferase
T21 138-181 http://purl.obolibrary.org/obo/GO_0001888 denotes activity of N-acetylglucosaminyltransferase
T22 138-181 http://purl.obolibrary.org/obo/GO_0003829 denotes activity of N-acetylglucosaminyltransferase
T23 138-181 http://purl.obolibrary.org/obo/GO_0008109 denotes activity of N-acetylglucosaminyltransferase
T24 422-431 http://purl.obolibrary.org/obo/GO_0023052 denotes signaling
T25 422-439 http://purl.obolibrary.org/obo/GO_0007165 denotes signaling pathway
T26 571-577 http://purl.obolibrary.org/obo/GO_0040007 denotes growth
T27 1303-1309 http://purl.obolibrary.org/obo/GO_0040007 denotes growth
T28 1443-1449 http://purl.obolibrary.org/obo/GO_0040007 denotes growth
T29 571-591 http://purl.obolibrary.org/obo/GO_0045926 denotes growth and inhibited
T30 812-815 http://purl.obolibrary.org/obo/GO_0004021 denotes GPT
T31 890-906 http://purl.obolibrary.org/obo/GO_0033674 denotes activated kinase
T32 1061-1077 http://purl.obolibrary.org/obo/GO_0033674 denotes activated kinase
T33 890-906 http://purl.obolibrary.org/obo/GO_0016301 denotes activated kinase
T34 1061-1077 http://purl.obolibrary.org/obo/GO_0016301 denotes activated kinase
T35 890-908 http://purl.obolibrary.org/obo/GO_0050254 denotes activated kinase 1
T36 890-908 http://purl.obolibrary.org/obo/GO_0052835 denotes activated kinase 1
T37 890-908 http://purl.obolibrary.org/obo/GO_0004707 denotes activated kinase 1
T38 890-908 http://purl.obolibrary.org/obo/GO_0004715 denotes activated kinase 1
T39 890-908 http://purl.obolibrary.org/obo/GO_0019140 denotes activated kinase 1
T40 890-908 http://purl.obolibrary.org/obo/GO_0047944 denotes activated kinase 1
T41 1061-1087 http://purl.obolibrary.org/obo/GO_0004860 denotes activated kinase inhibitor
T42 1061-1087 http://purl.obolibrary.org/obo/GO_0008384 denotes activated kinase inhibitor
T43 1061-1087 http://purl.obolibrary.org/obo/GO_0007249 denotes activated kinase inhibitor
T44 1061-1087 http://purl.obolibrary.org/obo/GO_0019210 denotes activated kinase inhibitor
T45 1071-1087 http://purl.obolibrary.org/obo/GO_0033673 denotes kinase inhibitor
T46 1366-1383 http://purl.obolibrary.org/obo/GO_0033673 denotes kinase inhibitors
T47 1246-1259 http://purl.obolibrary.org/obo/GO_0070085 denotes glycosylation
T48 1772-1785 http://purl.obolibrary.org/obo/GO_0070085 denotes glycosylation
T49 1274-1289 http://purl.obolibrary.org/obo/GO_0016310 denotes phosphorylation

GO-MF

Id Subject Object Predicate Lexical cue
T1 1303-1325 http://purl.obolibrary.org/obo/GO_0070851 denotes growth factor receptor

GO-CC

Id Subject Object Predicate Lexical cue
T1 51-56 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T2 612-617 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T3 1169-1174 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T4 1345-1350 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T5 1583-1588 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T6 1913-1918 http://purl.obolibrary.org/obo/GO_0005623 denotes cells

Allie

Id Subject Object Predicate Lexical cue
SS1_23811795_1_0 195-219 expanded denotes hepatocellular carcinoma
SS2_23811795_1_0 221-224 abbr denotes HCC
SS1_23811795_5_0 886-908 expanded denotes p21-activated kinase 1
SS2_23811795_5_0 910-914 abbr denotes PAK1
SS1_23811795_6_0 1293-1325 expanded denotes epidermal growth factor receptor
SS2_23811795_6_0 1327-1331 abbr denotes EGFR
AE1_23811795_1_0 SS1_23811795_1_0 SS2_23811795_1_0 abbreviatedTo hepatocellular carcinoma,HCC
AE1_23811795_5_0 SS1_23811795_5_0 SS2_23811795_5_0 abbreviatedTo p21-activated kinase 1,PAK1
AE1_23811795_6_0 SS1_23811795_6_0 SS2_23811795_6_0 abbreviatedTo epidermal growth factor receptor,EGFR

PubmedHPO

Id Subject Object Predicate Lexical cue
T1 195-219 HP_0001402 denotes hepatocellular carcinoma
T2 262-267 HP_0002664 denotes tumor
T3 997-1001 HP_0000365 denotes dead

GlyTouCan-IUPAC

Id Subject Object Predicate Lexical cue
GlycanIUPAC_T1 784-790 "http://rdf.glycoinfo.org/glycan/G26693XF" denotes GlcNAc
GlycanIUPAC_T2 1228-1234 "http://rdf.glycoinfo.org/glycan/G26693XF" denotes GlcNAc
GlycanIUPAC_T3 1754-1760 "http://rdf.glycoinfo.org/glycan/G26693XF" denotes GlcNAc
GlycanIUPAC_T4 784-790 "http://rdf.glycoinfo.org/glycan/G01864SU" denotes GlcNAc
GlycanIUPAC_T5 1228-1234 "http://rdf.glycoinfo.org/glycan/G01864SU" denotes GlcNAc
GlycanIUPAC_T6 1754-1760 "http://rdf.glycoinfo.org/glycan/G01864SU" denotes GlcNAc
GlycanIUPAC_T7 784-790 "http://rdf.glycoinfo.org/glycan/G17605FD" denotes GlcNAc
GlycanIUPAC_T8 1228-1234 "http://rdf.glycoinfo.org/glycan/G17605FD" denotes GlcNAc
GlycanIUPAC_T9 1754-1760 "http://rdf.glycoinfo.org/glycan/G17605FD" denotes GlcNAc
GlycanIUPAC_T10 784-790 "http://rdf.glycoinfo.org/glycan/G41950LU" denotes GlcNAc
GlycanIUPAC_T11 1228-1234 "http://rdf.glycoinfo.org/glycan/G41950LU" denotes GlcNAc
GlycanIUPAC_T12 1754-1760 "http://rdf.glycoinfo.org/glycan/G41950LU" denotes GlcNAc
GlycanIUPAC_T13 784-790 "http://rdf.glycoinfo.org/glycan/G57195RJ" denotes GlcNAc
GlycanIUPAC_T14 1228-1234 "http://rdf.glycoinfo.org/glycan/G57195RJ" denotes GlcNAc
GlycanIUPAC_T15 1754-1760 "http://rdf.glycoinfo.org/glycan/G57195RJ" denotes GlcNAc
GlycanIUPAC_T16 784-790 "http://rdf.glycoinfo.org/glycan/G85391SA" denotes GlcNAc
GlycanIUPAC_T17 1228-1234 "http://rdf.glycoinfo.org/glycan/G85391SA" denotes GlcNAc
GlycanIUPAC_T18 1754-1760 "http://rdf.glycoinfo.org/glycan/G85391SA" denotes GlcNAc
GlycanIUPAC_T19 784-790 "http://rdf.glycoinfo.org/glycan/G89565QL" denotes GlcNAc
GlycanIUPAC_T20 1228-1234 "http://rdf.glycoinfo.org/glycan/G89565QL" denotes GlcNAc
GlycanIUPAC_T21 1754-1760 "http://rdf.glycoinfo.org/glycan/G89565QL" denotes GlcNAc
GlycanIUPAC_T22 784-790 "http://rdf.glycoinfo.org/glycan/G80869MR" denotes GlcNAc
GlycanIUPAC_T23 1228-1234 "http://rdf.glycoinfo.org/glycan/G80869MR" denotes GlcNAc
GlycanIUPAC_T24 1754-1760 "http://rdf.glycoinfo.org/glycan/G80869MR" denotes GlcNAc
GlycanIUPAC_T25 784-790 "http://rdf.glycoinfo.org/glycan/G55978NL" denotes GlcNAc
GlycanIUPAC_T26 1228-1234 "http://rdf.glycoinfo.org/glycan/G55978NL" denotes GlcNAc
GlycanIUPAC_T27 1754-1760 "http://rdf.glycoinfo.org/glycan/G55978NL" denotes GlcNAc
GlycanIUPAC_T28 784-790 "http://rdf.glycoinfo.org/glycan/G54644LT" denotes GlcNAc
GlycanIUPAC_T29 1228-1234 "http://rdf.glycoinfo.org/glycan/G54644LT" denotes GlcNAc
GlycanIUPAC_T30 1754-1760 "http://rdf.glycoinfo.org/glycan/G54644LT" denotes GlcNAc
GlycanIUPAC_T31 784-790 "http://rdf.glycoinfo.org/glycan/G25694UG" denotes GlcNAc
GlycanIUPAC_T32 1228-1234 "http://rdf.glycoinfo.org/glycan/G25694UG" denotes GlcNAc
GlycanIUPAC_T33 1754-1760 "http://rdf.glycoinfo.org/glycan/G25694UG" denotes GlcNAc
GlycanIUPAC_T34 784-790 "http://rdf.glycoinfo.org/glycan/G25126RB" denotes GlcNAc
GlycanIUPAC_T35 1228-1234 "http://rdf.glycoinfo.org/glycan/G25126RB" denotes GlcNAc
GlycanIUPAC_T36 1754-1760 "http://rdf.glycoinfo.org/glycan/G25126RB" denotes GlcNAc
GlycanIUPAC_T37 784-790 "http://rdf.glycoinfo.org/glycan/G51848AD" denotes GlcNAc
GlycanIUPAC_T38 1228-1234 "http://rdf.glycoinfo.org/glycan/G51848AD" denotes GlcNAc
GlycanIUPAC_T39 1754-1760 "http://rdf.glycoinfo.org/glycan/G51848AD" denotes GlcNAc
GlycanIUPAC_T40 784-790 "http://rdf.glycoinfo.org/glycan/G94667GM" denotes GlcNAc
GlycanIUPAC_T41 1228-1234 "http://rdf.glycoinfo.org/glycan/G94667GM" denotes GlcNAc
GlycanIUPAC_T42 1754-1760 "http://rdf.glycoinfo.org/glycan/G94667GM" denotes GlcNAc
GlycanIUPAC_T43 784-790 "http://rdf.glycoinfo.org/glycan/G30124BO" denotes GlcNAc
GlycanIUPAC_T44 1228-1234 "http://rdf.glycoinfo.org/glycan/G30124BO" denotes GlcNAc
GlycanIUPAC_T45 1754-1760 "http://rdf.glycoinfo.org/glycan/G30124BO" denotes GlcNAc
GlycanIUPAC_T46 784-790 "http://rdf.glycoinfo.org/glycan/G82777EZ" denotes GlcNAc
GlycanIUPAC_T47 1228-1234 "http://rdf.glycoinfo.org/glycan/G82777EZ" denotes GlcNAc
GlycanIUPAC_T48 1754-1760 "http://rdf.glycoinfo.org/glycan/G82777EZ" denotes GlcNAc
GlycanIUPAC_T49 784-790 "http://rdf.glycoinfo.org/glycan/G10151YZ" denotes GlcNAc
GlycanIUPAC_T50 1228-1234 "http://rdf.glycoinfo.org/glycan/G10151YZ" denotes GlcNAc
GlycanIUPAC_T51 1754-1760 "http://rdf.glycoinfo.org/glycan/G10151YZ" denotes GlcNAc
GlycanIUPAC_T52 784-790 "http://rdf.glycoinfo.org/glycan/G17585ZM" denotes GlcNAc
GlycanIUPAC_T53 1228-1234 "http://rdf.glycoinfo.org/glycan/G17585ZM" denotes GlcNAc
GlycanIUPAC_T54 1754-1760 "http://rdf.glycoinfo.org/glycan/G17585ZM" denotes GlcNAc
GlycanIUPAC_T55 784-790 "http://rdf.glycoinfo.org/glycan/G04411CJ" denotes GlcNAc
GlycanIUPAC_T56 1228-1234 "http://rdf.glycoinfo.org/glycan/G04411CJ" denotes GlcNAc
GlycanIUPAC_T57 1754-1760 "http://rdf.glycoinfo.org/glycan/G04411CJ" denotes GlcNAc
GlycanIUPAC_T58 784-790 "http://rdf.glycoinfo.org/glycan/G38254HJ" denotes GlcNAc
GlycanIUPAC_T59 1228-1234 "http://rdf.glycoinfo.org/glycan/G38254HJ" denotes GlcNAc
GlycanIUPAC_T60 1754-1760 "http://rdf.glycoinfo.org/glycan/G38254HJ" denotes GlcNAc
GlycanIUPAC_T61 784-790 "http://rdf.glycoinfo.org/glycan/G75188FS" denotes GlcNAc
GlycanIUPAC_T62 1228-1234 "http://rdf.glycoinfo.org/glycan/G75188FS" denotes GlcNAc
GlycanIUPAC_T63 1754-1760 "http://rdf.glycoinfo.org/glycan/G75188FS" denotes GlcNAc
GlycanIUPAC_T64 784-790 "http://rdf.glycoinfo.org/glycan/G70374VG" denotes GlcNAc
GlycanIUPAC_T65 1228-1234 "http://rdf.glycoinfo.org/glycan/G70374VG" denotes GlcNAc
GlycanIUPAC_T66 1754-1760 "http://rdf.glycoinfo.org/glycan/G70374VG" denotes GlcNAc
GlycanIUPAC_T67 784-790 "http://rdf.glycoinfo.org/glycan/G45176LJ" denotes GlcNAc
GlycanIUPAC_T68 1228-1234 "http://rdf.glycoinfo.org/glycan/G45176LJ" denotes GlcNAc
GlycanIUPAC_T69 1754-1760 "http://rdf.glycoinfo.org/glycan/G45176LJ" denotes GlcNAc
GlycanIUPAC_T70 784-790 "http://rdf.glycoinfo.org/glycan/G30874VW" denotes GlcNAc
GlycanIUPAC_T71 1228-1234 "http://rdf.glycoinfo.org/glycan/G30874VW" denotes GlcNAc
GlycanIUPAC_T72 1754-1760 "http://rdf.glycoinfo.org/glycan/G30874VW" denotes GlcNAc
GlycanIUPAC_T73 784-790 "http://rdf.glycoinfo.org/glycan/G69333MI" denotes GlcNAc
GlycanIUPAC_T74 1228-1234 "http://rdf.glycoinfo.org/glycan/G69333MI" denotes GlcNAc
GlycanIUPAC_T75 1754-1760 "http://rdf.glycoinfo.org/glycan/G69333MI" denotes GlcNAc
GlycanIUPAC_T76 784-790 "http://rdf.glycoinfo.org/glycan/G10676XO" denotes GlcNAc
GlycanIUPAC_T77 1228-1234 "http://rdf.glycoinfo.org/glycan/G10676XO" denotes GlcNAc
GlycanIUPAC_T78 1754-1760 "http://rdf.glycoinfo.org/glycan/G10676XO" denotes GlcNAc
GlycanIUPAC_T79 784-790 "http://rdf.glycoinfo.org/glycan/G14843DJ" denotes GlcNAc
GlycanIUPAC_T80 1228-1234 "http://rdf.glycoinfo.org/glycan/G14843DJ" denotes GlcNAc
GlycanIUPAC_T81 1754-1760 "http://rdf.glycoinfo.org/glycan/G14843DJ" denotes GlcNAc
GlycanIUPAC_T82 784-790 "http://rdf.glycoinfo.org/glycan/G47546FR" denotes GlcNAc
GlycanIUPAC_T83 1228-1234 "http://rdf.glycoinfo.org/glycan/G47546FR" denotes GlcNAc
GlycanIUPAC_T84 1754-1760 "http://rdf.glycoinfo.org/glycan/G47546FR" denotes GlcNAc
GlycanIUPAC_T85 784-790 "http://rdf.glycoinfo.org/glycan/G73695ZM" denotes GlcNAc
GlycanIUPAC_T86 1228-1234 "http://rdf.glycoinfo.org/glycan/G73695ZM" denotes GlcNAc
GlycanIUPAC_T87 1754-1760 "http://rdf.glycoinfo.org/glycan/G73695ZM" denotes GlcNAc
GlycanIUPAC_T88 784-790 "http://rdf.glycoinfo.org/glycan/G31923TJ" denotes GlcNAc
GlycanIUPAC_T89 1228-1234 "http://rdf.glycoinfo.org/glycan/G31923TJ" denotes GlcNAc
GlycanIUPAC_T90 1754-1760 "http://rdf.glycoinfo.org/glycan/G31923TJ" denotes GlcNAc
GlycanIUPAC_T91 784-790 "http://rdf.glycoinfo.org/glycan/G60519EP" denotes GlcNAc
GlycanIUPAC_T92 1228-1234 "http://rdf.glycoinfo.org/glycan/G60519EP" denotes GlcNAc
GlycanIUPAC_T93 1754-1760 "http://rdf.glycoinfo.org/glycan/G60519EP" denotes GlcNAc
GlycanIUPAC_T94 784-790 "http://rdf.glycoinfo.org/glycan/G07933IA" denotes GlcNAc
GlycanIUPAC_T95 1228-1234 "http://rdf.glycoinfo.org/glycan/G07933IA" denotes GlcNAc
GlycanIUPAC_T96 1754-1760 "http://rdf.glycoinfo.org/glycan/G07933IA" denotes GlcNAc
GlycanIUPAC_T97 784-790 "http://rdf.glycoinfo.org/glycan/G40745NH" denotes GlcNAc
GlycanIUPAC_T98 1228-1234 "http://rdf.glycoinfo.org/glycan/G40745NH" denotes GlcNAc
GlycanIUPAC_T99 1754-1760 "http://rdf.glycoinfo.org/glycan/G40745NH" denotes GlcNAc
GlycanIUPAC_T100 784-790 "http://rdf.glycoinfo.org/glycan/G54496YV" denotes GlcNAc
GlycanIUPAC_T101 1228-1234 "http://rdf.glycoinfo.org/glycan/G54496YV" denotes GlcNAc
GlycanIUPAC_T102 1754-1760 "http://rdf.glycoinfo.org/glycan/G54496YV" denotes GlcNAc
GlycanIUPAC_T103 784-790 "http://rdf.glycoinfo.org/glycan/G62953SQ" denotes GlcNAc
GlycanIUPAC_T104 1228-1234 "http://rdf.glycoinfo.org/glycan/G62953SQ" denotes GlcNAc
GlycanIUPAC_T105 1754-1760 "http://rdf.glycoinfo.org/glycan/G62953SQ" denotes GlcNAc
GlycanIUPAC_T106 784-790 "http://rdf.glycoinfo.org/glycan/G70070AY" denotes GlcNAc
GlycanIUPAC_T107 1228-1234 "http://rdf.glycoinfo.org/glycan/G70070AY" denotes GlcNAc
GlycanIUPAC_T108 1754-1760 "http://rdf.glycoinfo.org/glycan/G70070AY" denotes GlcNAc
GlycanIUPAC_T109 784-790 "http://rdf.glycoinfo.org/glycan/G78792WC" denotes GlcNAc
GlycanIUPAC_T110 1228-1234 "http://rdf.glycoinfo.org/glycan/G78792WC" denotes GlcNAc
GlycanIUPAC_T111 1754-1760 "http://rdf.glycoinfo.org/glycan/G78792WC" denotes GlcNAc
GlycanIUPAC_T112 784-790 "http://rdf.glycoinfo.org/glycan/G25238AV" denotes GlcNAc
GlycanIUPAC_T113 1228-1234 "http://rdf.glycoinfo.org/glycan/G25238AV" denotes GlcNAc
GlycanIUPAC_T114 1754-1760 "http://rdf.glycoinfo.org/glycan/G25238AV" denotes GlcNAc
GlycanIUPAC_T115 784-790 "http://rdf.glycoinfo.org/glycan/G40510DP" denotes GlcNAc
GlycanIUPAC_T116 1228-1234 "http://rdf.glycoinfo.org/glycan/G40510DP" denotes GlcNAc
GlycanIUPAC_T117 1754-1760 "http://rdf.glycoinfo.org/glycan/G40510DP" denotes GlcNAc
GlycanIUPAC_T118 784-790 "http://rdf.glycoinfo.org/glycan/G61120TK" denotes GlcNAc
GlycanIUPAC_T119 1228-1234 "http://rdf.glycoinfo.org/glycan/G61120TK" denotes GlcNAc
GlycanIUPAC_T120 1754-1760 "http://rdf.glycoinfo.org/glycan/G61120TK" denotes GlcNAc
GlycanIUPAC_T121 784-790 "http://rdf.glycoinfo.org/glycan/G41342KV" denotes GlcNAc
GlycanIUPAC_T122 1228-1234 "http://rdf.glycoinfo.org/glycan/G41342KV" denotes GlcNAc
GlycanIUPAC_T123 1754-1760 "http://rdf.glycoinfo.org/glycan/G41342KV" denotes GlcNAc
GlycanIUPAC_T124 784-790 "http://rdf.glycoinfo.org/glycan/G90703NA" denotes GlcNAc
GlycanIUPAC_T125 1228-1234 "http://rdf.glycoinfo.org/glycan/G90703NA" denotes GlcNAc
GlycanIUPAC_T126 1754-1760 "http://rdf.glycoinfo.org/glycan/G90703NA" denotes GlcNAc
GlycanIUPAC_T127 784-790 "http://rdf.glycoinfo.org/glycan/G01591HR" denotes GlcNAc
GlycanIUPAC_T128 1228-1234 "http://rdf.glycoinfo.org/glycan/G01591HR" denotes GlcNAc
GlycanIUPAC_T129 1754-1760 "http://rdf.glycoinfo.org/glycan/G01591HR" denotes GlcNAc
GlycanIUPAC_T130 784-790 "http://rdf.glycoinfo.org/glycan/G56520XN" denotes GlcNAc
GlycanIUPAC_T131 1228-1234 "http://rdf.glycoinfo.org/glycan/G56520XN" denotes GlcNAc
GlycanIUPAC_T132 1754-1760 "http://rdf.glycoinfo.org/glycan/G56520XN" denotes GlcNAc
GlycanIUPAC_T133 784-790 "http://rdf.glycoinfo.org/glycan/G81830JX" denotes GlcNAc
GlycanIUPAC_T134 1228-1234 "http://rdf.glycoinfo.org/glycan/G81830JX" denotes GlcNAc
GlycanIUPAC_T135 1754-1760 "http://rdf.glycoinfo.org/glycan/G81830JX" denotes GlcNAc

NGLY1-deficiency

Id Subject Object Predicate Lexical cue
PD-NGLY1-deficiency-B_T1 762-782 chem:24139 denotes N-acetyl glucosamine
PD-NGLY1-deficiency-B_T2 784-790 chem:24139 denotes GlcNAc
PD-NGLY1-deficiency-B_T3 1228-1234 chem:24139 denotes GlcNAc
PD-NGLY1-deficiency-B_T4 1754-1760 chem:24139 denotes GlcNAc

HP-phenotype

Id Subject Object Predicate Lexical cue hp_id
T1 195-219 Phenotype denotes hepatocellular carcinoma HP:0001402
T2 221-224 Phenotype denotes HCC HP:0001402
T3 262-267 Phenotype denotes tumor HP:0002664
T4 2061-2064 Phenotype denotes HCC HP:0001402

mondo_disease

Id Subject Object Predicate Lexical cue mondo_id
T1 42-50 Disease denotes hepatoma http://purl.obolibrary.org/obo/MONDO_0007256
T2 195-219 Disease denotes hepatocellular carcinoma http://purl.obolibrary.org/obo/MONDO_0007256
T3 221-224 Disease denotes HCC http://purl.obolibrary.org/obo/MONDO_0007256
T4 262-267 Disease denotes tumor http://purl.obolibrary.org/obo/MONDO_0005070
T5 447-455 Disease denotes hepatoma http://purl.obolibrary.org/obo/MONDO_0007256
T6 603-611 Disease denotes hepatoma http://purl.obolibrary.org/obo/MONDO_0007256
T7 1160-1168 Disease denotes hepatoma http://purl.obolibrary.org/obo/MONDO_0007256
T8 1336-1344 Disease denotes hepatoma http://purl.obolibrary.org/obo/MONDO_0007256
T9 1574-1582 Disease denotes hepatoma http://purl.obolibrary.org/obo/MONDO_0007256
T10 1904-1912 Disease denotes hepatoma http://purl.obolibrary.org/obo/MONDO_0007256
T11 2061-2064 Disease denotes HCC http://purl.obolibrary.org/obo/MONDO_0007256

Anatomy-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T1 1293-1309 Body_part denotes epidermal growth http://purl.obolibrary.org/obo/UBERON_0000021